查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614374

固定劑量設備市場：按設備類型、適應症、分銷管道和最終用戶分類 - 2025-2030 年全球預測

Fixed Dose Device Market by Device Type (Inhalers, Injectors, Nasal Sprays), Indication (Cardiovascular Diseases, Diabetes, Respiratory Disorders), Distribution Channel, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年固定劑量器械市場價值為91.7億美元，預計到2024年將達到100.3億美元，複合年成長率為9.78%，到2030年將達到176.3億美元。

固定劑量設備市場包括旨在準確管理預設劑量藥物的醫療傳輸設備。這個市場對於確保一致的藥物傳遞和最小的使用者錯誤至關重要，這對於需要嚴格劑量的治療（例如糖尿病的胰島素）至關重要。對計量裝置的需求源自於對劑量準確性、病人依從性和易用性的需求，尤其是在居家照護環境中。其應用涵蓋多種治療領域，包括慢性病、疼痛管理和緊急藥物管理。最終用戶主要是患者、醫療保健專業人員和家庭護理師。該市場的主要成長要素是慢性病盛行率的增加、人口老化的加劇以及家庭醫療保健的成長趨勢。智慧和連網型設備等醫療技術的進步為加強患者管理和疾病監測提供了重要機會。然而，市場開拓可能會受到先進設備的高成本、監管挑戰以及開發新醫療設備相關的複雜性等因素的阻礙。為了應對這些限制，公司可以專注於具有成本效益的製造流程，並與醫療保健提供者合作，簡化監管核准流程。創新地，有潛力開發整合人工智慧的設備，以進行即時患者回饋和依從性監測。此外，增加設備連接性可以實現更好的資料分析和患者管理解決方案。對生物分解性和患者客製化設計的研究也可以刺激業務成長。由於技術進步和不斷變化的患者需求，市場競爭激烈且快速發展。希望利用這一市場的公司需要投資於研發，注重策略夥伴關係關係，並靈活應對監管變化和競爭環境，以確保成長和市場滲透。

主要市場統計
基準年[2023] 91.7億美元
預計年份 [2024] 100.3億美元
預測年份 [2030] 176.3億美元
複合年成長率（%） 9.78%

市場動態：針對快速發展的固定劑量設備市場所揭示的關鍵市場見解

供需的動態交互作用正在改變固定劑量設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 由於慢性病的流行，對持續用藥管理的需求增加
    • 由於方便和準確，計量裝置迅速普及
  • 市場限制因素
    • 固定劑量裝置的開發和製造成本較高
  • 市場機會
    • 科技不斷進步，開發智慧計量筆
    • 藥廠加大定量裝置研發投入
  • 市場挑戰
    • 政府機構嚴格的監管標準和複雜的核准流程

波特的五力：駕馭固定劑量設備市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解固定劑量設備市場的外部影響

外部宏觀環境因素在塑造固定劑量設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解固定劑量裝置市場的競爭格局

固定劑量設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣固定劑量設備市場供應商的績效評估

FPNV 定位矩陣是評估固定劑量設備市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪固定劑量設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對固定劑量設備市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病的增加增加了對持續藥物管理的需求
      • 便利性和準確性導致固定劑量設備的快速採用
    • 抑制因素
      • 開發和製造固定劑量裝置的成本高昂
    • 機會
      • 持續技術進步，開發智慧固定劑量筆
      • 藥廠加大固定劑量器材研發投入
    • 任務
      • 政府機構嚴格的監管標準和複雜的核准流程
  • 市場區隔分析
    • 設備類型：鼻噴劑因其有效輸送藥物而受到青睞
    • 配送通路：拓展線上配送通路，方便偏遠地區配送
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依設備類型分類的固定劑量設備市場

  • 吸入器
  • 注射器
  • 鼻噴劑
  • 經皮吸收貼片

第7章依適應症分類的固定劑量裝置市場

  • 心血管疾病
  • 糖尿病
  • 呼吸系統疾病

第8章固定劑量設備市場：按分銷管道

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第9章固定劑量設備市場：依最終用戶分類

  • 家庭護理設置
  • 醫院/診所

第10章美洲固定劑量設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太固定劑量設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的固定劑量設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 印度製藥商旨在透過非專利藥 Wegovy 佔領全球減重藥市場
    • 歐盟對禮來公司用於糖尿病治療的多劑量注射筆「Mounjaro」進行監管審查
    • 諾和諾德以 1.54 億美元收購 BioCorp，擴大產品組合
  • 戰略分析和建議

公司名單

  • Becton, Dickinson and Company
  • CeQur Corporation
  • Eli Lilly and Company
  • Gerresheimer AG
  • Insulet Corporation
  • Medtronic plc
  • Nemera Development SA
  • Novo Holdings A/S
  • Owen Mumford Limited
  • Phillips-Medisize by Koch Industries, Inc.
  • Sanofi Winthrop Industrie
  • SHL Medical AG.
  • Solteam Incorporation Co., Ltd.
  • SOOIL Developments Co., Ltd
  • Tandem Diabetes Care, Inc.
  • Tata Elxsi Limited by Tata Group
  • West Pharmaceutical Services, Inc.
  • Wilhelm Haselmeier GmbH & Co
  • Ypsomed Holding AG
Product Code: MRR-5D693B46C669

The Fixed Dose Device Market was valued at USD 9.17 billion in 2023, expected to reach USD 10.03 billion in 2024, and is projected to grow at a CAGR of 9.78%, to USD 17.63 billion by 2030.

The fixed dose device market encompasses medical delivery devices designed to administer a precise and pre-set quantity of medication. This market is vital in ensuring consistent drug delivery with minimal user error, which is critical for treatments requiring strict dosage adherence, like insulin for diabetes. The necessity of fixed dose devices arises from the need for accuracy in dosing, patient compliance, and ease of use, especially in home-care settings. Their applications span various therapeutic areas including chronic diseases, pain management, and emergency medication administration. End-users predominantly include patients, healthcare professionals, and home nurses. Key growth factors for this market are the increasing incidence of chronic diseases, a growing aging population, and the rising trend of home healthcare. Advancements in medical technology, such as smart and connected devices, offer substantial opportunities for enhanced patient management and disease monitoring. However, market growth may be hampered by factors like high costs of advanced devices, regulatory challenges, and the complexities involved in developing devices for new drugs. To counter these limitations, companies can focus on cost-effective manufacturing processes and work with healthcare providers to streamline regulatory approval processes. Innovatively, there is potential in developing devices with integrated AI for real-time patient feedback and adherence monitoring. Moreover, enhancing device connectivity could allow for better data analytics and patient management solutions. Researching biodegradability and patient-customized designs may also spur business growth. The nature of the fixed dose device market is competitive and rapidly evolving, driven by technological advancements and shifting patient needs. Companies seeking to capitalize on this market should invest in R&D, focus on strategic partnerships, and remain agile to adapt to regulatory changes and competitive environments, ensuring robust growth and market penetration.

KEY MARKET STATISTICS
Base Year [2023] USD 9.17 billion
Estimated Year [2024] USD 10.03 billion
Forecast Year [2030] USD 17.63 billion
CAGR (%) 9.78%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fixed Dose Device Market

The Fixed Dose Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased demand for consistent medication management due to growing prevalence of chronic disease
    • Rapid adoption of fixed-dose devices due to its convenience and accuracy
  • Market Restraints
    • High costs of development and manufacturing of fixed dose device
  • Market Opportunities
    • Ongoing technological advancements for the development of smart fixed-dose pens
    • Rising investments in research and development of fixed-dose devices by pharmaceutical companies
  • Market Challenges
    • Stringent regulatory norms and complex approval processes by government bodies

Porter's Five Forces: A Strategic Tool for Navigating the Fixed Dose Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fixed Dose Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fixed Dose Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fixed Dose Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fixed Dose Device Market

A detailed market share analysis in the Fixed Dose Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fixed Dose Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fixed Dose Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fixed Dose Device Market

A strategic analysis of the Fixed Dose Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fixed Dose Device Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, CeQur Corporation, Eli Lilly and Company, Gerresheimer AG, Insulet Corporation, Medtronic plc, Nemera Development S.A., Novo Holdings A/S, Owen Mumford Limited, Phillips-Medisize by Koch Industries, Inc., Sanofi Winthrop Industrie, SHL Medical AG., Solteam Incorporation Co., Ltd., SOOIL Developments Co., Ltd, Tandem Diabetes Care, Inc., Tata Elxsi Limited by Tata Group, West Pharmaceutical Services, Inc., Wilhelm Haselmeier GmbH & Co, and Ypsomed Holding AG.

Market Segmentation & Coverage

This research report categorizes the Fixed Dose Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across Inhalers, Injectors, Nasal Sprays, and Transdermal Patches.
  • Based on Indication, market is studied across Cardiovascular Diseases, Diabetes, and Respiratory Disorders.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on End-User, market is studied across Home Care Settings and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased demand for consistent medication management due to growing prevalence of chronic disease
      • 5.1.1.2. Rapid adoption of fixed-dose devices due to its convenience and accuracy
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of development and manufacturing of fixed dose device
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological advancements for the development of smart fixed-dose pens
      • 5.1.3.2. Rising investments in research and development of fixed-dose devices by pharmaceutical companies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory norms and complex approval processes by government bodies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device Type: Preference towards nasal spray due to its efficient delivery of drugs
    • 5.2.2. Distribution Channel: Expanding online delivery channels due to convenient delivery for remote locations
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fixed Dose Device Market, by Device Type

  • 6.1. Introduction
  • 6.2. Inhalers
  • 6.3. Injectors
  • 6.4. Nasal Sprays
  • 6.5. Transdermal Patches

7. Fixed Dose Device Market, by Indication

  • 7.1. Introduction
  • 7.2. Cardiovascular Diseases
  • 7.3. Diabetes
  • 7.4. Respiratory Disorders

8. Fixed Dose Device Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Fixed Dose Device Market, by End-User

  • 9.1. Introduction
  • 9.2. Home Care Settings
  • 9.3. Hospitals & Clinics

10. Americas Fixed Dose Device Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Fixed Dose Device Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Fixed Dose Device Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Indian Pharmaceutical Firms Target Global Weight-Loss Drug Market with Generic Versions of Wegovy
    • 13.3.2. EU Regulatory Review of Lilly's Mounjaro Multi-Dose Pen for Diabetes Treatment
    • 13.3.3. Novo Nordisk Expands Portfolio with USD 154 Million Acquisition of Biocorp
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Becton, Dickinson and Company
  • 2. CeQur Corporation
  • 3. Eli Lilly and Company
  • 4. Gerresheimer AG
  • 5. Insulet Corporation
  • 6. Medtronic plc
  • 7. Nemera Development S.A.
  • 8. Novo Holdings A/S
  • 9. Owen Mumford Limited
  • 10. Phillips-Medisize by Koch Industries, Inc.
  • 11. Sanofi Winthrop Industrie
  • 12. SHL Medical AG.
  • 13. Solteam Incorporation Co., Ltd.
  • 14. SOOIL Developments Co., Ltd
  • 15. Tandem Diabetes Care, Inc.
  • 16. Tata Elxsi Limited by Tata Group
  • 17. West Pharmaceutical Services, Inc.
  • 18. Wilhelm Haselmeier GmbH & Co
  • 19. Ypsomed Holding AG

LIST OF FIGURES

  • FIGURE 1. FIXED DOSE DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. FIXED DOSE DEVICE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FIXED DOSE DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES FIXED DOSE DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES FIXED DOSE DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. FIXED DOSE DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. FIXED DOSE DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FIXED DOSE DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FIXED DOSE DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FIXED DOSE DEVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY NASAL SPRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES FIXED DOSE DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. FIXED DOSE DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. FIXED DOSE DEVICE MARKET, FPNV POSITIONING MATRIX, 2023